Morning Analysis on Top Gainers -- Research on Molycorp, Vanda Pharma, Uranium Energy, and Odyssey Marine Exploration

LONDON, June 5, 2014 /PRNewswire/ --

The US markets saw a positive sentiment on Wednesday, June 04, 2014, with the NASDAQ Composite closing at 4,251.64, up 0.41%, the Dow Jones Industrial Average ending the session 0.09% higher at 16,737.53, and the S&P 500 edging 0.19% higher to finish the trading session at 1,927.88. During the session gains in the Consumer Discretionary, Financials and Consumer Staples sectors positively impacted the broader market, while some retraction came in from Telecommunication Services, Energy and Industrials sectors. Investor-Edge has initiated coverage on the following equities: Molycorp Inc. (NYSE: MCP), Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), Uranium Energy Corp. (NYSE MKT: UEC) and Odyssey Marine Exploration Inc. (NASDAQ: OMEX). Free technical research on MCP, VNDA, UEC and OMEX can be downloaded upon signing up at:

http://www.investor-edge.com/3446-register

Shares in Molycorp Inc. finished Wednesday's session 11.60% higher at $2.79. A total of 8.48 million shares were traded, which was above its three months average volume of 5.04 million shares. The stock moved between $2.52 and $2.83 during the session. Although, Molycorp Inc.'s stock has advanced 0.72% in the previous three trading sessions, it has declined 41.39% in the last one month months and 50.36% on YTD basis. The S&P 500 Materials Sector Index mapped a gain of 0.18% during the trading session, and the same charted up 3.35% in the last one month. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $5.16 is greater than its 50-day moving average of $4.10. Molycorp Inc.'s stock has a Relative Strength Index (RSI) of 18.78. Sign up today to read free research on MCP at:

http://www.investor-edge.com/3446-MCP-05Jun2014.pdf

On Wednesday, Vanda Pharmaceuticals Inc.'s stock fluctuated between $11.00 and $12.99 before ending the session 25.35% higher at $12.56. Vanda Pharmaceuticals Inc.'s stock reported a trading volume of 4.82 million shares, much above its three months average volume of 1.10 million shares. Over the last three trading sessions and since start of this year, Vanda Pharmaceuticals Inc.'s shares have gained 22.06% and 1.21%, respectively. However, the company's stock has fallen by 13.44% in the last one month. The S&P 500 Health Care Sector Index registered a gain of 0.23% during the trading session, with the index also advancing 3.81% in the last one month. The stock is trading above its 200-day moving average of $12.16. Moreover, shares of the company have an RSI of 36.52. Sign up today to read free research on VNDA at:

http://www.investor-edge.com/3446-VNDA-05Jun2014.pdf

On Wednesday, Uranium Energy Corp.'s stock rallied 12.18%, closing the day at $1.75. The stock recorded a trading volume of 2.10 million shares, above its three months average volume of 1.91 million shares. The stock oscillated between $1.57 and $1.75 during the trading session. Uranium Energy Corp.'s shares have declined 12.06% in the last three months and 12.50% since beginning of this year. However, the stock has surged 66.67% on the previous one month. The S&P 500 Energy Sector Index reported a loss of 0.14% during the trading session, while the same charted up 8.14% in the last three months. The stock is trading above its 50-day moving average of $1.30, while the 50-day moving average is below Uranium Energy Corp.'s 200-day moving average of $1.77. Additionally, the stock has an RSI of 53.81. Sign up today to read free research on UEC at:

http://www.investor-edge.com/3446-UEC-05Jun2014.pdf

On Wednesday, Odyssey Marine Exploration Inc.'s stock recorded a trading volume of 2.57 million shares, which was above its three months average volume of 0.87 million shares. The stock ended the day at $1.51, which was 19.84% above its previous day's closing, and registered an intraday range of $1.18 and $1.57. Odyssey Marine Exploration Inc.'s share has surged 9.42% in the previous three trading sessions. However, the company's stock has declined 28.44% in the last one month and 25.25% since beginning of this year. The S&P 500 Industrials Sector Index mapped a loss of 0.08% during the trading session, while the index has charted up 3.31% in the last three months. Odyssey Marine Exploration Inc.'s shares are trading below their 50-day and 200-day moving averages of $1.95 and $2.26, respectively. The company's stock has an RSI of 24.42. Sign up today to read free research on OMEX at:

http://www.investor-edge.com/3446-OMEX-05Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge